171 related articles for article (PubMed ID: 21930971)
21. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
Mooijaart SP; Koeijvoets KM; Sijbrands EJ; Daha MR; Westendorp RG
Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
[TBL] [Abstract][Full Text] [Related]
22. Age-related macular degeneration: a perspective on genetic studies.
Patel N; Adewoyin T; Chong NV
Eye (Lond); 2008 Jun; 22(6):768-76. PubMed ID: 17491602
[TBL] [Abstract][Full Text] [Related]
23. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
Hughes AE; Orr N; Esfandiary H; Diaz-Torres M; Goodship T; Chakravarthy U
Nat Genet; 2006 Oct; 38(10):1173-7. PubMed ID: 16998489
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.
Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments.
Chen M; Forrester JV; Xu H
Exp Eye Res; 2007 Apr; 84(4):635-45. PubMed ID: 17292886
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
27. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
[TBL] [Abstract][Full Text] [Related]
28. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology.
Clark SJ; Bishop PN; Day AJ
Biochem Soc Trans; 2010 Oct; 38(5):1342-8. PubMed ID: 20863311
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration.
Giralt L; Figueras-Roca M; Eguileor BL; Romero B; Zarranz-Ventura J; Alforja S; Santiago F; Bolaños J; Lozano F; Dotti-Boada M; Sala-Puigdollers A; Dura P; Izquierdo-Serra J; Valero O; Adan A; Fonollosa A; Molins B
Front Immunol; 2024; 15():1330913. PubMed ID: 38633250
[TBL] [Abstract][Full Text] [Related]
30. Monomeric C-reactive protein and inflammation in age-related macular degeneration.
Chirco KR; Whitmore SS; Wang K; Potempa LA; Halder JA; Stone EM; Tucker BA; Mullins RF
J Pathol; 2016 Oct; 240(2):173-83. PubMed ID: 27376713
[TBL] [Abstract][Full Text] [Related]
31. Activation of C-reactive protein proinflammatory phenotype in the blood retinal barrier
Romero-Vázquez S; Adán A; Figueras-Roca M; Llorenç V; Slevin M; Vilahur G; Badimon L; Dick AD; Molins B
Aging (Albany NY); 2020 Jul; 12(14):13905-13923. PubMed ID: 32673285
[TBL] [Abstract][Full Text] [Related]
32. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
Okemefuna AI; Nan R; Miller A; Gor J; Perkins SJ
J Biol Chem; 2010 Jan; 285(2):1053-65. PubMed ID: 19850925
[TBL] [Abstract][Full Text] [Related]
33. Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin.
O'Flynn J; van der Pol P; Dixon KO; Prohászka Z; Daha MR; van Kooten C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1308-16. PubMed ID: 26984957
[TBL] [Abstract][Full Text] [Related]
34. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form.
Clark SJ; Higman VA; Mulloy B; Perkins SJ; Lea SM; Sim RB; Day AJ
J Biol Chem; 2006 Aug; 281(34):24713-20. PubMed ID: 16787919
[TBL] [Abstract][Full Text] [Related]
35. Complement factor H binds to denatured rather than to native pentameric C-reactive protein.
Hakobyan S; Harris CL; van den Berg CW; Fernandez-Alonso MC; de Jorge EG; de Cordoba SR; Rivas G; Mangione P; Pepys MB; Morgan BP
J Biol Chem; 2008 Nov; 283(45):30451-60. PubMed ID: 18786923
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of serum and ocular levels of membrane attack complex and C-reactive protein in CFH-genotyped human donors.
Chirco KR; Flamme-Wiese MJ; Wiley JS; Potempa LA; Stone EM; Tucker BA; Mullins RF
Eye (Lond); 2018 Nov; 32(11):1740-1742. PubMed ID: 30013157
[TBL] [Abstract][Full Text] [Related]
37. Complement factor H and macular degeneration: the genome yields an important clue.
Wiggs JL
Arch Ophthalmol; 2006 Apr; 124(4):577-8. PubMed ID: 16606888
[No Abstract] [Full Text] [Related]
38. The role of complement in AMD.
Zipfel PF; Lauer N; Skerka C
Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
[TBL] [Abstract][Full Text] [Related]
39. Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells.
Schäfer N; Rasras A; Ormenisan DM; Amslinger S; Enzmann V; Jägle H; Pauly D
Front Immunol; 2021; 12():769242. PubMed ID: 34819935
[TBL] [Abstract][Full Text] [Related]
40. Aged complement factor H knockout mice kept in a clean barriered environment have reduced retinal pathology.
Hoh Kam J; Morgan JE; Jeffery G
Exp Eye Res; 2016 Aug; 149():116-125. PubMed ID: 27397653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
